Fig. 6From: Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin’s lymphoma: a systematic review and meta-analysisMeta-analysis of clinical outcomes between HCV-associated NHL patients receiving rituximab-containing chemotherapy and rituximab-free chemotherapy. a Overall survival (OS); b progression-free survival (PFS)Back to article page